详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.

78| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China. [2]Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, 100142, P. R. China. [3]Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China. [4]Department of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, 100142, P. R. China. [5]Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P. R. China. [6]Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310006, P. R. China. [7]Department of Medical Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, P. R. China. [8]Department of Surgical Oncology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, P. R. China. [9]Department of Medical Oncology, Fujian Cancer Hospital, Fuzhou, Fujian, 350000, P. R. China. [10]Department of Medical Oncology, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, 430030, P. R. China. [11]Cancer Center of The First Hospital of Jilin University, Changchun, Jilin, 130021, P. R. China. [12]Department of Pathology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China. [13]Department of Endoscopy Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, 100142, P. R. China. [14]Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, P. R. China. [15]Department of Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China. [16]Department of Radiotherapy, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China. [17]Department of Medical Oncology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, 200032, P. R. China. [18]Department of Abdominal Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, P. R. China. [19]Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China. [20]Pathology Laboratory of Gastrointestinal Tumor, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P. R. China. [21]Department of Pathology, Zhongshan Hospital Affiliated to Shanghai Fudan University, Shanghai, 200032, P. R. China. [22]Department of Gastrointestinal Oncology Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P. R. China. [23]Department of Gastrointestinal Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, 100142, P. R. China. [24]Department of Gastric Surgery, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, P. R. China. [25]Department of Gastrointestinal Medical Oncology, Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang, 150081, P. R. China. [26]Department of Radiation Oncology, Shenzhen Center, Cancer Hospital of Chinese Academy of Medical Sciences, Shenzhen, 518000, P. R. China. [27]Department of Oncology, East Hospital Affiliated to Shanghai Tongji University, Shanghai, 200120, P. R. China.

出处：

DOI：

ISSN：

摘要：

There exist differences in the epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selections between gastric cancer patients from the Eastern and Western countries. The Chinese Society of Clinical Oncology (CSCO) has organized a panel of senior experts specializing in all sub-specialties of gastric cancer to compile a clinical guideline for the diagnosis and treatment of gastric cancer since 2016 and renews it annually. Taking into account regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted expert consensus judgment on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes in China. The 2021 CSCO Clinical Practice Guidelines for Gastric Cancer covers the diagnosis, treatment, follow-up, and screening of gastric cancer. Based on the 2020 version of the CSCO Chinese Gastric Cancer guidelines, this updated guideline integrates the results of major clinical studies from China and overseas for the past year, focused on the inclusion of research data from the Chinese population for more personalized and clinically relevant recommendations. For the comprehensive treatment of non-metastatic gastric cancer, attentions were paid to neoadjuvant treatment. The value of perioperative chemotherapy is gradually becoming clearer and its recommendation level has been updated. For the comprehensive treatment of metastatic gastric cancer, recommendations for immunotherapy were included, and immune checkpoint inhibitors from third-line to the first-line of treatment for different patient groups with detailed notes are provided.© 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat-sen University Cancer Center.

语种：

高被引：

热点：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2023]版：

大类 | 1 区医学

小类 | 2 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

影响因子： 20.1 最新[2023版] 16.7 最新五年平均 15.283 出版当年[2021版] 13.163 出版当年五年平均 10.392 出版前一年[2020版] 16.2 出版后一年[2022版]

第一作者：

第一作者机构： [1]Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China.

共同第一作者：

通讯作者：

通讯机构： [1]Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China. [*1]Department of Medical Oncology, SunYat-senUniversityCancer Center StateKey Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, P.R.China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. $(function () { $("[data-toggle='tooltip']").tooltip(); });

文献详情

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.